ONCOLYTIC VACCINIA VIRUSES AND RECOMBINANT VIRUSES AND METHODS OF USE THEREOF

NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

ONCOLYTIC VACCINIA VIRUSES AND RECOMBINANT VIRUSES AND METHODS OF USE THEREOF

ETHER LIPIDS FOR HYPERACTIVATION OF MAMMALIAN DENDRITIC CELLS

NADC34-LIKE PRRSV-2 VACCINE CANDIDATE STRAIN AND APPLICATION THEREOF

TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

BIVALENT INACTIVATED EV71-CA16 VACCINE, METHOD FOR PREPARING THE SAME, AND USE THEREOF

Combination Vaccine For Prevention Of Influenza And Coronavirus Infections

PREPARATION OF INFLUENZA VIRUS VACCINE ANTIGENS

METHOD FOR MANUFACTURING INACTIVATED SARS-COV-2 VACCINE, INACTIVATED SARS-COV-2 VACCINE, METHOD FOR PURIFYING SARS-COV-2 OR INACTIVATED SARS-COV-2, AND SARS-COV-2 ANTIGEN COMPOSITION OR INACTIVATED SARS-COV-2 ANTIGEN COMPOSITION

CULTURE METHOD FOR FISH CELLS AND CELL CULTURE MEDIUM USED THEREIN, AND ORAL VACCINE FOR FISH

LIPID POLYSACCHARIDE AMINO ACID NANOPARTICLES AND USE THEREOF

INFLUENZA VIRUS VACCINES AND USES THEREOF

PREFUSION RSV F PROTEINS AND THEIR USE

ZIKA VACCINES AND IMMUNOGENIC COMPOSITIONS, AND METHODS OF USING THE SAME

USE OF MATRIX BOUND VESICLES (MBV) AS VACCINE ADJUVANTS

PREFUSION RSV F PROTEINS AND THEIR USE

UV-C VIRUS INACTIVATION DEVICES AND SUPRESSING SOUND AND OPERATING THE SAME

Coxsackievirus B Compositions and Methods Of Use Thereof

PORCINE ENDOGENOUS RETROVIRUS (PERV)-FREE PORCINE CIRCOVIRUS TYPE 2D-BASED VACCINES AND METHODS OF USE

ANTI-GUCY2C VACCINES AND VACCINATION

SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES

RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED NA

SYSTEM FOR PRODUCING AND DELIVERING CONTACTLESS VETERINARY PASSIVE IMMUNIZATION

RECOMBINANT NEWCASTLE DISEASE VIRUS EXPRESSING LASSA VIRUS GP OR NP, AND USES THEREOF

TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION

SALMONELLA FREE EGG PRODUCTION METHODS AND SYSTEMS

THERMOSTABLE UV INACTIVATED VACCINES AND OTHER BIOPHARMACEUTICALS

HEPATITIS A VIRUS PREPARATION METHOD AND HEPATITIS A VIRUS PREPARED ACCORDING TO METHOD

HYPERACTIVATING LIPID NANOPARTICLES

METHODS OF PRODUCING CELLS RESISTANT TO HIV INFECTION

PORCINE CORONAVIRUS VACCINES

FREEZE-DRIED VIRAL COMBINATION VACCINE COMPOSITIONS AND PROCESS FOR PREPARATION THEREOF

A THERAPEUTIC AGAINST CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS

CORONAVIRUS VACCINE FORMULATIONS

Zika Virus Vaccine

COXSACKIEVIRUS B4 STRAIN AND APPLICATION THEREOF

SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES

MEDICATION FOR INFLUENZA

MULTI-CBV VACCINE FOR PREVENTING OR TREATING TYPE I DIABETES

TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

UNIVERSAL VACCINE FOR INFLUENZA VIRUS BASED ON TETRAMERIC M2 PROTEIN INCORPORATED INTO NANODISCS

Novel Adjuvant Compositions

METHOD OF PRODUCING AN IMMUNOGENIC COMPOSITION

SYNERGISM OF IMMUNOGENICITY VIA COMBINED PARENTERAL AND MUCOSAL IMMUNIZATION AGAINST COVID-19

NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

METHOD FOR INACTIVATING ZIKA VIRUS AND FOR DETERMINING THE COMPLETENESS OF INACTIVATION

IRRADIATION-INACTIVATED POLIOVIRUS, COMPOSITIONS INCLUDING THE SAME, AND METHODS OF PREPARATION

INACTIVATED SARS-COV-2 VIRUS VACCINE

ZIKA VACCINES AND IMMUNOGENIC COMPOSITIONS, AND METHODS OF USING THE SAME

RABIES VIRUS VACCINE

INORGANIC POLYATOMIC OXYANIONS FOR PROTECTING AGAINST ANTIGENIC DAMAGE DURING PATHOGEN INACTIVATION FOR VACCINE PRODUCTION

MESENCHYMAL STEM CELLS AS VACCINE ADJUVANTS AND METHODS FOR USING THE SAME

COMBINED AGONIST ADJUVANT FOR CORONAVIRUS VACCINE

NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus

Prefusion RSV F proteins and their use

ENGINEERED INFLUENZA VIRUSES EXPRESSING SARS-COV-2 ANTIGENS, VACCINES AND METHODS OF MAKING AND USING THE SAME

Methods for Providing a Vaccine

A VACCINE ADJUVANT FOR INFECTIOUS DISEASES

Liquid six combined vaccine composition

Foot-and-mouth disease vaccine

PSEUDORABIES VIRUS VACCINE

METHOD FOR THE PROPHYLAXIS OR TREATMENT OF CORONAVIRUS INFECTION USING AN IMMUNOMODULATOR AND VACCINE COMPOSITIONS COMPRISING THE SAME

VIRUS VACCINE BASED ON VIRUS SURFACE ENGINEERING PROVIDING INCREASED IMMUNITY

Personalized Site-Specific Immunomodulation

INFLUENZA VACCINE FOR INTRANASAL ADMINISTRATION

VACCINES AND IMMUNOGLOBULINS TARGETING AFRICAN SWINE FEVER VIRUS, METHODS OF PREPARING SAME, AND METHODS OF USING SAME

TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION

INFLUENZA VACCINE

N PROTEIN EPITOPE MUTATION MARKER FOR PREPARING EPITOPE DELETION-MARKED VACCINE STRAIN OF TYPE II PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) AND USE THEREOF

MICROPARTICLE COMPOSITIONS AND METHODS USE THEREOF

Compositions, methods and uses for thermally stable multi-targeted antigens

SYSTEMS AND METHODS FOR ADMINISTERING VACCINE COMPOSITION USING MODULAR MULTI-VIAL MICROCHANNEL DELIVERY ADAPTER DEVICES

Zika virus vaccine

SUSTAINED RELEASE INACTIVATED VACCINES

CORONAVIRUS VACCINE AND METHOD FOR PREPARATION THEREOF

REDUCED FOAMING VACCINE COMPOSITIONS

METHODS AND COMPOSITIONS FOR SENSITIZING PRC2 MUTANT TUMORS TO IMMUNE CHECKPOINT BLOCKADE THERAPY

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

METHOD FOR PRODUCING AN ANTIGEN CORRESPONDING TO THE INACTIVATED SARS-COV-2 VIRUS, ANTIGEN CORRESPONDING TO THE INACTIVATED SARS-COV-2 VIRUS, ANTIGENIC COMPOSITION, KITS, AND USES THEREOF

Prefusion RSV F proteins and their use

RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED NA

Zika vaccines and immunogenic compositions, and methods of using the same

GENE SHUFFLED LYSSAVIRUS VACCINE

Zika vaccines and immunogenic compositions, and methods of using the same

USING FUNGAL CONSTRUCTS TO PRODUCE VIRAL PROTEIN ANTIGENS

UNIVERSAL MAMMALIAN INFLUENZA VACCINE

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS

INFLUENZA VIRUSES WITH MUTANT PB2 GENE SEGMENT AS LIVE ATTENUATED VACCINES

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

RSV F protein compositions and methods for making same

Production Of Vaccines Comprising Inactivated SARS-COV-2 Viral Particles

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

NOVEL SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS

Coronavirus disease (COVID-19) vaccine

Immune complex

Removal of agglomerates

BROAD SPECTRUM INFLUENZA VIRUS VACCINE

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

MANNOSE CONJUGATED CHITOSAN-BASED INFLUENZA NANOVACCINE FORMULATIONS AND USES THEREOF

COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS

CD1 PEPTIDE-EPITOPE FOR USE IN THE TREATMENT OF A DISEASE CAUSED BY AN INTRACELLULAR PATHOGEN

ONCOLYTIC VIRUSES AS ADJUVANTS

Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same

VIRAL VACCINE COMPOSITIONS AND METHODS OF PREPARATIONS THEREOF

Inactivation of Genome Enveloped within Coronavirus Spherical or Pleomorphic Particles or Shells to Form a Vaccine

RECOMBINANT VACCINE AGAINST COVID-19 BASED ON A PARAMYXOVIRUS VIRAL VECTOR

Zika virus vaccine

COMPOSITIONS AND METHODS FOR PRODUCING A VIRAL VACCINE WITH REDUCED PARTICLE SIZE

INFLUENZA VACCINE

JAPANESE ENCEPHALITIS PREVENTIVE AGENT AND JAPANESE ENCEPHALITIS VACCINE AGENT

RABBIT HAEMORRHAGIC DISEASE VIRUS (RHDV) VACCINES

COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF MARINE MOLLUSC VIRAL INFECTION

VIRAL NUCLEIC ACID MOLECULES, AND COMPOSITIONS AND METHODS OF USE THEREOF

METHOD FOR PRODUCING INACTIVATED INFLUENZA VACCINE AND VACCINE COMPOSITION THEREOF

Method for inactivating zika virus and for determining the completeness of inactivation

Compositions and Administration of Chimeric Glycoprotein Lyssavirus Vaccines for Coverage Against Rabies

Methods Of Treating Multiple Sclerosis

Stable, Spray Dried, Immunogenic, Viral Compositions

PHARMACEUTICAL COMPOSITION COMPRISING POLYNUCLEOTIDES AND USE THEREOF FOR PREVENTION OR TREATMENT OF COVID-19

STABILIZED 9 AND 10 SEGMENTED INFLUENZA VIRUSES AS A VACCINE PLATFORM AND METHODS OF MAKING AND USING SAME

Coronavirus disease (COVID-19) vaccine

Virus purification

Composition comprising PIC for treatment of cancer

Method of producing an immunogenic composition

F-GENOTYPE MUMPS VIRUS ATTENUATED STRAIN AND CONSTRUCTION METHOD THEREFOR AND APPLICATION THEREOF

PEPTIDE VACCINE BASED ON A NEW UNIVERSAL INFLUENZA A HEMAGGLUTININ HEAD DOMAIN EPITOPE AND HUMAN MONOCLONAL ANTIBODIES BINDING THERETO

RSV F protein compositions and methods for making same

COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS

Vaccine delivery method

RSV F protein compositions and methods for making same

SEASONAL INFLUENZA VACCINE CAPABLE OF INDUCING VIRUS-SPECIFIC ANTIBODY INTO NASAL CAVITY

SENECAVIRUS A IMMUNOGENIC COMPOSITIONS AND METHODS THEREOF

Immunogenic Antigens

Zika virus vaccine

ENGINEERED VACCINIA VIRUS

Vaccine Adjuvants for Antigen Delivery

INFLUENZA VIRUS NEURAMINIDASE AND USES THEREOF

SENECAVIRUS A VIRUS STRAINS AND IMMUNOGENIC COMPOSITIONS THEREFROM

REDUCED FOAMING VACCINE COMPOSITIONS

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

VACCINATION AGAINST CORONAVIRUS WITH POLIOMYELITIS VACCINE

VIRAL VACCINES AND METHODS OF FORMING THE SAME

RSV F protein compositions and methods for making same

INACTIVATED VIRUS COMPOSITIONS AND ZIKA VACCINE FORMULATIONS

Methods for Inducing a Safe Immune Response Against Polio Virus

Compositions, methods and uses for thermally stable multi-targeted antigens

ADJUVANTED MULTIVALENT INFLUENZA VACCINES

TLR4-TLR7 LIGAND FORMULATIONS AS VACCINE ADJUVANTS

COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS

METHODS FOR PREPARING ALUMINUM PRECIPITATE COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINES

Immunogenic Antigens

Materials and methods for respiratory disease control in canines

STABILIZED NON-ENVELOPED VIRUS COMPOSITIONS

Enhancing Immunity Using Chimeric CD40 Ligand and Coronavirus Vaccine

Foot-and-mouth disease vaccine

Prefusion RSV F proteins and their use

Immunological adjuvant composition, preparation method and application thereof

Rabies composition comprising PIKA adjuvant

Human rotavirus G9P[6] strain and use as a vaccine

Inactivated whole-virus influenza vaccine and method for preparing same

Recombinant nucleic acid of Seneca valley virus, recombinant vaccine strain and preparation method and use thereof

Human antibodies to Fel d1 and methods of use thereof

Compositions Useful in Both Homologous And Heterologous Vaccine Regimens

Immunogenic composition against avian influenza virus H5 subtype

METHODS FOR INACTIVATING AND STORING RESPIRATORY SYNCYTIAL VIRUS

PREFUSION RSV F PROTEINS AND THEIR USE

METHOD FOR INACTIVATING ZIKA VIRUS AND RELATED METHODS

NOVEL METHODS OF VACCINATION USING ICOSAHEDRAL PHAGE

THERMAL INACTIVATION OF ROTAVIRUS

Method for the prophylaxis or treatment of coronavirus infection using an immunomodulator and vaccine compositions comprising the same

Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same

Adjuvant compositions

USE OF A TLR9 AGONIST IN METHODS FOR TREATING COVID-19

VACCINATION AGAINST CORONAVIRUS WITH POLIOMYELITIS VACCINE

Human rotavirus strains and vaccines

Vaccines against avian reoviruses

LIPOSOME COMPOSITIONS COMPRISING PAM2CYS OR PAM3CYS ADJUVANT AND METHODS FOR INDUCING A HUMORAL IMMUNE RESPONSE

Isolation of a novel pestivirus causing congenital tremor A

UV-C VIRUS INACTIVATION DEVICES AND SUPRESSING SOUND AND OPERATING THE SAME

SYSTEMS AND METHODS FOR UV-C INACTIVATED VIRUS VACCINES AND UV-C SANITIZATION

MICRODEVICES WITH COMPLEX GEOMETRIES

RECOMBINANT BIOLOGICALLY CONTAINED FILOVIRUS VACCINE

Virus vaccination system and methods

Nucleic acids encoding chimeric dengue/Zika viruses optimized for growth and stability in vero cells

METHOD FOR EVALUATING ANTI-INFECTIVE DRUGS, VACCINES, ETC. USING IMMORTALIZED MONOCYTIC CELLS AND INDUCED CELLS

Removal of agglomerates

Recombinant influenza viruses with stabilized NA

Recombinant H7N9 subtype avian influenza virus, inactivated marked vaccine and preparation method thereof

Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccination

STEM CELLS COMPRISING SYNTHETIC CHIMERIC VACCINIA VIRUS AND METHODS OF USING THEM

Viral particle-based vaccine

Immune complex

Multi-CBV vaccine for preventing or treating type I diabetes

Preparation of influenza virus vaccine antigens

Utilizing Vaccines to Treat Cancer and Enhance the Success Rate of Cancer Immunotherapy

Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production

Broad spectrum influenza virus vaccine

Vaccine compositions

HEAT-INACTIVATED VACCINIA VIRUS AS A VACCINE IMMUNE ADJUVANT

Method for inactivating Zika virus and for determining the completeness of inactivation

Zika vaccines and immunogenic compositions, and methods of using the same

Triple vaccine against and avian encephalomyelitis virus and fowl pox virus

Compositions and administration of chimeric glycoprotein lyssavirus vaccines for coverage against rabies

ANTI-TUMORAL COMPOSITION

Irradiation-inactivated poliovirus, compositions including the same, and methods of preparation

Methods of producing cells resistant to HIV infection

Severe fever with thrombocytopenia syndrome virus

Composition, preparation method and evaluation of a complex immunogen named I-SPGA for production of immunological active proteins (IAP)

compositions and methods thereof

Broadly protective inactivated influenza virus vaccine

Zika virus purification

Vaccines with enhanced immunogenicity, low allergenicity and reactogenicity

COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS

Vaccine composition and method of preventing porcine epidemic diarrhea virus infection in swine

Respiratory syncytial virus (RSV) vaccines

Multi-CBV vaccine for preventing or treating type 1 diabetes

Vaccine delivery method

Immunopotentiator, foot-and-mouth disease inactivated vaccine and preparation method thereof

Engineered vaccinia virus

Mucosal adjuvants and delivery systems

ONCOLYTIC VIRUSES AS ADJUVANTS

Stable, spray dried, immunogenic, viral compositions

Methods and compositions useful in generating non canonical CD8+ T cell responses

SMC COMBINATION THERAPY FOR THE TREATMENT OF CANCER

Zika virus vaccine

Cell-derived viral vaccines with low levels of residual cell DNA

Process for enterovirus purification and inactivation and vaccine compositions obtained thereof

CHIKV RNA vaccines

Virus purification

Aluminum compounds for use in therapeutics and vaccines

H7 avian influenza vaccine strain which differentiates infected from vaccinated animals, preparation method therefor, and application

Influenza vaccine

Zika vaccines and immunogenic compositions, and methods of using the same

Methods of manufacturing an immunogenic composition comprising a recombinant protein

MEDICATION FOR INFLUENZA

PCV/mycoplasma hyopneumoniae vaccine

Mycoplasma hyopneumoniae vaccine

Composition comprising iscom particles and live micro-organisms

H9 avian influenza vaccine strain which differentiates infected from vaccinated animals, and preparation method therefor

Method of inhibiting enveloped virus binding to target cells by incorporating P-selectin glycoprotein ligand-1 (PSGL-1) into virions

MUCOADHESIVE NANOPARTICLE ENTRAPPED INFLUENZA VIRUS VACCINE DELIVERY SYSTEM

Senecavirus a immunogenic compositions and methods thereof

Method and system for inactivating virus infectivity for producing live-attenuated vaccines

H5 avian influenza vaccine strain which differentiates infected from vaccinated animals, preparation method therefor, and application

Methods and Compositions for the Prevention and Treatment of Influenza

Influenza viruses with mutant PB2 gene segment as live attenuated vaccines

Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors

Recombinant bivalent inactivated vaccine against foot-and-mouth disease virus, preparation method and use thereof

Photochemical preparation method for autologous plasma inactivated vaccine for treating AIDS

Cross-protective pathogen protection, methods and compositions thereof

Mixture of non-digestible oligosaccharides for stimulating the immune system

Immunogenic composition having improved stability, enhanced immunogenicity and reduced reactogenicity and process for preparation thereof

Virus purification

REDUCED FOAMING VACCINE COMPOSITIONS

Porcine epidemic diarrhea virus S protein and subunit vaccine thereof as well as method for preparing subunit vaccine and application thereof

RSV F protein compositions and method for making same

CMV-based intra-tumoral cancer therapies

INFLUENZA VIRUS REASSORTMENT

COMPOSITIONS AND METHODS FOR PRODUCTION OF COLD-CHAIN VACCINES

Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers

Thermal inactivation of rotavirus

Human rotavirus G9P[6] strain and use as a vaccine

Personalized Site-Specific Immunomodulation

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen

ANTIGENIC THERMOSTABLE POLIO VACCINES & RELATED METHODS

Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein

Foot-and-mouth disease vaccine

Human rotavirus strains and vaccines

Porcine coronavirus vaccines

Epizootic hemorrhagic disease vaccine

Multi-CBV vaccine for preventing or treating type I diabetes

Porcine circovirus type 3 strain, vaccine composition, method of making the same and use thereof

Vaccines and Diagnostics for Novel Porcine Orthoreoviruses

Stable, spray dried, immunogenic, viral compositions

Universal mammalian influenza vaccine

Materials and methods for respiratory disease control in canines

Immune complex

Chimeric west nile/zika viruses and methods of use

Method for preparing foot-and-mouth disease vaccines

Method and system for inactivating virus infectivity for producing live-attenuated vaccines

Mucosal adjuvants and delivery systems

Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same

Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus

Multi-CBV vaccine for preventing or treating type I diabetes

PCV/vaccine for use with PRRSV vaccine

Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production

Multivalent vaccine composition

Marker system, in particular for baculovirus-expressed subunit antigens

Methods of making solid vaccine compositions having reduced foaming

Duck enteritis virus and the uses thereof

Duck enteritis virus and the uses thereof

Influenza vaccines

Liposome compositions comprising PAM2Cys or PAM3Cys adjuvant and methods for inducing a humoral immune response

LOW-ADDITIVE INFLUENZA VACCINES